Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective (Q41065642)

26 September 2017

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective (English)

1 reference

26 September 2017

1 reference

1 reference

M Melegari

1

1 reference

26 September 2017

P P Scaglioni

series ordinal

2

1 reference

26 September 2017

J R Wands

series ordinal

3

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

26 September 2017

1 reference

26 September 2017

27

1 reference

26 September 2017

628-633

1 reference

26 September 2017

2

1 reference

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Identification of four conserved motifs among the RNA-dependent polymerase encoding elements

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Characterization of hepatitis B virus core mutants that inhibit viral replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Properties of hepatitis B virus pre-S1 deletion mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

The implications of drug resistance for strategies of combination antiviral chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270243

7 January 2021

Identifiers

DOI

10.1002/HEP.510270243

1 reference

release_h3hl3hqcrjddfkb2mejkzlgij4

26 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h3hl3hqcrjddfkb2mejkzlgij4

24 November 2022

mapped directly with Wikidata item

1 reference